Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 2.810
+0.010 (0.36%)
Jul 16, 2025, 1:59 PM EDT
Medexus Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Medexus Pharmaceuticals had annual revenue of $108.33M USD, down -4.18%. Medexus Pharmaceuticals had revenue of $24.75M in the quarter ending March 31, 2025, a decrease of -4.65%.
Revenue
$108.33M
Revenue Growth
-4.18%
P/S Ratio
0.58
Revenue / Employee
$1.19M
Employees
91
Market Cap
90.32M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 108.33M | -4.72M | -4.18% |
| Mar 31, 2024 | 113.05M | 4.96M | 4.59% |
| Mar 31, 2023 | 108.10M | 31.40M | 40.93% |
| Mar 31, 2022 | 76.70M | -2.96M | -3.71% |
| Mar 31, 2021 | 79.66M | 24.15M | 43.52% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.58B |
| WELL Health Technologies | 990.34M |
| Trulieve Cannabis | 1.71B |
| Extendicare | 1.47B |
| Cronos Group | 179.08M |
| Curaleaf Holdings | 1.89B |